As of 2025-07-06, the Fair Value of Bioxytran Inc (BIXT) is -0.16 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.10 USD, the upside of Bioxytran Inc is -263.19%.
With the market price of 0.10 USD and our fair value calculation, Bioxytran Inc (BIXT) is not a good investment. Investing in BIXT stocks now will result in a potential loss of 263.19%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 5Y Avg | |
| Net income | -0.32 | -0.30 | -1.86 | -2.48 | -4.03 | -1.80 |
| YoY growth | 54.30% | 6.90% | -526.98% | -33.48% | -62.53% | -112.36% |
| Market Cap (mil) | 8.89 |
| P/E | |
| Forward P/E |
| EPS | -0.03 |
| Avg earnings growth rate | -112.36% |
| TTM earnings | -2.90 |